Swine Health

Swine Health

Global Swine Health Market to Reach US$4.1 Billion by 2030

The global market for Swine Health estimated at US$2.8 Billion in the year 2023, is expected to reach US$4.1 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$2.5 Billion by the end of the analysis period. Growth in the Vaccines segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$735.0 Million While China is Forecast to Grow at 9.9% CAGR

The Swine Health market in the U.S. is estimated at US$735.0 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$981.9 Million by the year 2030 trailing a CAGR of 9.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.1% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Swine Health Market - Key Trends and Drivers Summarized

Why Is Swine Health Gaining Importance in Livestock Management?

Swine health is becoming increasingly important in livestock management due to rising concerns about disease outbreaks, biosecurity, and overall animal welfare. Pork production is one of the most significant sectors of global meat production, and maintaining the health of swine populations is critical to ensuring sustainable and safe pork supply. The spread of diseases such as African swine fever (ASF) has highlighted the vulnerabilities within global supply chains, leading to heightened awareness around the importance of preventive health measures. Farms and producers are adopting more comprehensive health programs to monitor and improve swine immunity, manage outbreaks, and ensure the quality and safety of pork products.

How Are Advancements in Veterinary Medicine Shaping the Swine Health Market?

Technological advancements in veterinary medicine are playing a critical role in improving swine health outcomes. Innovations such as vaccine development, biosecurity measures, and diagnostic tools are enabling early disease detection and more effective treatments. For instance, novel vaccines targeting swine diseases are reducing the mortality rates associated with common illnesses such as Porcine Reproductive and Respiratory Syndrome (PRRS). Additionally, digital health monitoring systems allow farmers to track the health of their livestock in real-time, optimizing treatment plans and improving herd management. The rising integration of artificial intelligence and biotechnology in the animal health industry further drives innovation in this sector.

What Are the Key Segments Driving the Growth of the Swine Health Market?

Vaccines remain one of the leading segments, as they are crucial for preventing major outbreaks and protecting swine populations from viral diseases. Diagnostics is another critical segment, with advances in laboratory testing and real-time disease tracking providing early warning systems for potential outbreaks. Feed additives, including probiotics and antibiotics, are used to improve digestion, promote growth, and maintain swine health. Geographically, North America and Europe lead in swine health innovation due to the high adoption of advanced veterinary practices, while the Asia-Pacific region shows significant growth potential as demand for pork rises.

What Factors Are Driving Growth in the Swine Health Market?

The growth in the swine health market is driven by several factors, including the increasing prevalence of swine diseases, advancements in vaccine development, and the growing awareness of animal welfare standards. The expanding pork industry and rising consumer demand for high-quality, disease-free meat are also contributing to the adoption of health solutions. Furthermore, governments and regulatory bodies are implementing stricter biosecurity measures, which are pushing farms to invest in comprehensive swine health management systems. The rise in research and development activities aimed at finding alternatives to antibiotics, and the growing focus on sustainable farming practices, are additional factors fueling market growth.

Select Competitors (Total 46 Featured) -

• Aptimmune Biologics, Inc.
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Dechra Pharmaceuticals PLC
• Elanco Animal Health
• Indian Immunologicals Ltd.
• Lillidale Animal Health
• Merck & Co., Inc.
• Merck Animal Health
• NEOGEN Corporation

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.